American Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
American Capital Management's NEO Position: Q2 2026 in Review
American Capital Management reduced its NeoGenomics (NEO) stake by 0.59% in Q2 2026, selling an estimated $127K and leaving 2,237,707 shares worth $32.6M. The position accounts for 1.46% of the portfolio, ranked #27.
American Capital Management first reported a position in NEO in Q4 2018 and has held it in 20 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- American Capital Management held 2,237,707 shares of NeoGenomics worth $32.6M as of Q2 2026.
- American Capital Management sold 13,171 NeoGenomics shares in Q2 2026, an estimated $127K.
- NeoGenomics made up 1.46% of American Capital Management's portfolio in Q2 2026, its #27 holding.
- American Capital Management first reported a position in NeoGenomics in Q4 2018 and has held it in 20 quarters since.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.